Interim Report 2026
Filed with HKEX · Stock code 3320 · · 111 pages · English and Chinese
China Resources Pharmaceutical Group Ltd. on 6ix
Earlier from China Resources Pharmaceutical
- Dividend currency election form for the interim dividend for the six months ended 30 June 2026
- AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI to Open a New Chapter in the Health Industry
- China Resources Pharmaceutical Logs FY Revenue RMB2.06 Bln For CR Boya Bio-Pharmaceutical
- Announcement unaudited financial results of jiangzhong pharmaceutical for the six months ended 30 June 2021
- China Resources Pharmaceutical Group: Unaudited financial results of cr pharmaceutical holdings for the three months ended 31 March 2021 in relation to issuances of corporate bonds and medium term notes in the prc
Later from China Resources Pharmaceutical
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Inside information potential issuance of shares by CR pharmaceutical commercial
- Inside information completion of the public issuance of the second tranche of 2026 corporate bonds in the PRC
- Inside information completion of the issue of the third tranche of the medium term notes 2026 in the prc
- Announcement unaudited financial results of tasly pharmaceutical for the nine months ended 30 September 2026
Follow China Resources Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Pharmaceutical